Me will hold a second auction for its DNA data with an opening bid of $305 million from former CEO Anne Wojcicki. Here's all ...

Nucleus Genomics launches IVF software that analyzes embryos for genetic risks and traits to aid parental choices.

Researchers have developed a blood test capable of rapidly diagnosing rare genetic diseases in babies and children, ...

Primary immunodeficiencies are notoriously difficult to identify because their wide-ranging symptoms can seem unrelated. This ...

Once a Silicon Valley pioneer in consumer genetic testing, 23andMe is now at the center of a high-stakes legal and financial ...

Caitlin Cronan wasn't going to have children if it meant passing along her kidney disease. Thankfully, her diagnosis wasn't the end of her motherhood journey.

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...

A rare genetic mutation in a European sperm donor has reportedly caused cancer in 10 children, highlighting the need for ...

A Brisbane nurse has been diagnosed with a brain tumour which she believes could’ve been discovered years earlier with ...

“Prioritizing Counseling in Genetic Counseling” was a thought-provoking workshop title at the 2025 European Society of Human ...

When direct-to-consumer genetic testing company 23andMe Holding Co. and its affiliates (together, “23andMe”) filed for chapter 11 bankruptcy on ...

Chung et al. examine the multi-dimensional effectiveness of genome sequencing and summarise indicators and measurement tools for psychosocial and economic outcomes. They highlight priority areas ...